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Assessing decision quality in patient-centred care requires a preferencesensitive measure
Abstract

A theory-based instrument for measuring the quality of decisions made using any form of decision
technology, including both decision-aided and unaided clinical consultations is required to enable person- and
patient-centred care and to respond positively to individual heterogeneity in the value aspects of decision
making. Current instruments using the term 'decision quality' have adopted a decision- and thus conditionspecific approach. We argue that patient-centred care requires decision quality to be regarded as both
preference-sensitive across multiple relevant criteria and generic across all conditions and decisions.
MyDecisionQuality is grounded in prescriptive multi criteria decision analysis and employs a simple expected
value algorithm to calculate a score for the quality of a decision that combines, in the clinical case, the patient's
individual preferences for eight quality criteria (expressed as importance weights) and their ratings of the
decision just taken on each of these criteria (expressed as performance rates). It thus provides an index of
decision quality that encompasses both these aspects. It also provides patients with help in prioritizing quality
criteria for future decision making by calculating, for each criterion, the Incremental Value of Perfect Rating,
that is, the increase in their decision quality score that would result if their performance rating on the criterion
had been 100%, weightings unchanged. MyDecisionQuality, which is a web-based generic and preferencesensitive instrument, can constitute a key patient-reported measure of the quality of the decision-making
process. It can provide the basis for future decision improvement, especially when the clinician (or other
stakeholders) completes the equivalent instrument and the extent and nature of concordance and discordance
can be established. Apart from its role in decision preparation and evaluation, it can also provide real time and
relevant documentation for the patient's record.
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Abstract
A theory-based instrument for measuring the quality of decisions made using any form of decision technology, including
both decision-aided and unaided clinical consultations is required to enable person- and patient-centred care and to
respond positively to individual heterogeneity in the value aspects of decision making. Current instruments using the
term ‘decision quality’ have adopted a decision- and thus condition-specific approach. We argue that patient-centred care
requires decision quality to be regarded as both preference-sensitive across multiple relevant criteria and generic across all
conditions and decisions. MyDecisionQuality is grounded in prescriptive multi criteria decision analysis and employs a
simple expected value algorithm to calculate a score for the quality of a decision that combines, in the clinical case, the
patient’s individual preferences for eight quality criteria (expressed as importance weights) and their ratings of the
decision just taken on each of these criteria (expressed as performance rates). It thus provides an index of decision
quality that encompasses both these aspects. It also provides patients with help in prioritizing quality criteria for future
decision making by calculating, for each criterion, the Incremental Value of Perfect Rating, that is, the increase in their
decision quality score that would result if their performance rating on the criterion had been 100%, weightings
unchanged. MyDecisionQuality, which is a web-based generic and preference-sensitive instrument, can constitute a
key patient-reported measure of the quality of the decision-making process. It can provide the basis for future decision
improvement, especially when the clinician (or other stakeholders) completes the equivalent instrument and the extent
and nature of concordance and discordance can be established. Apart from its role in decision preparation and evaluation, it can also provide real time and relevant documentation for the patient’s record.
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Background
The increase in the range of options available for health
and disease management, coupled with the shift
towards greater patient involvement in recent years,
has led to a profusion of decision aids and related support systems aimed at patient, clinician and medical
team.1–3 This has been followed by the development
of instruments and checklists to assess the quality of
such aids. Most have focused on the internal quality
of the particular decision aid as appraised by a set of
normative criteria, with the International Patient
Decision Aid Standards instrument (IPDASi)4 emerging as the most prominent of such checklists. Where
empirical evaluation has been undertaken or is proposed, most attention has been on particular process

and outcome aspects (e.g. acceptability, involvement,
conﬂict, knowledge), rather than on the comparative
performance of aided and unaided decision making in
relation to overall decision quality. (A list of evaluation
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measures is available on the Ottawa Patient Decision
Aids website, http://decisionaid.ohri.ca/eval.html)
None of the clinical trials included in the Cochrane
systematic review of decision aids has evaluated the
quality of the decisions derived from diﬀerent decision
technologies (including decision aids) using a single
index measure of overall decision quality. There is
therefore a need for evaluation measures that address
the overall quality of decisions, as distinct from measures that address particular aspects of decision making.
Adopting the Berwick5 philosophy of patient-centred
care implies that all decisions should be regarded as preference-sensitive, with the relative importance a patient
attaches to various outcomes and processes having a
large inﬂuence on, if not determining, what is decided.
This philosophy also necessitates that decision quality be
regarded as preference-sensitive and that the
relevant preferences are those of the patient facing
the decision, as opposed to the average preferences
of a group of patients with the same condition or
those of the health professional(s) involved in the
decision.
In the case of drugs or medical devices the main
purpose of the intervention is to achieve a health beneﬁt. It follows that the primary outcome of intervention
research is to determine its eﬀectiveness in accomplishing that task. We suggest that, in the case of decision
aids, the main purpose should be to enhance the overall
quality (‘goodness’) of the aided decision relative to
that which can be achieved without it – by some
other ‘decision technology’ – and that this should be
assessed at the time of decision making and not in terms
of any subsequent change or outcome.6 Hence, decision
quality should become the primary outcome of studies
comparing decision-aided and unaided practices. This
essay therefore argues for the use of decision quality as
a directly measurable patient-reported measure for all
health conditions. It could be regarded as a Patientreported outcome measure if the decision is regarded
as an outcome of the decision-making process7 or,
alternatively and more conventionally, as a patientreported experience measure.8 While policy makers
and researchers may beneﬁt from a generic measure,
the fundamental reason for it is so that the individual
is able to assess the quality of the various health-care
decisions they face in, and through, their life, using the
same instrument, whatever the context, condition,
timing in life or role occupied. We describe and illustrate the application of the MyDecisionQuality (MDQ)
instrument to this task.
The development of MDQ followed an assessment
of the available instruments for evaluating decision aids
– mainly on the Ottawa website – which was designed
to establish whether any of these instruments generated
a generic and preference-based index of overall decision
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quality; as opposed to ones that were: (i) condition-,
setting- or decision-speciﬁc; or (ii) measured one or
more possible aspects of decision making such as preferred involvement in decision,9 satisfaction with the
decision10 or decision conﬂict experienced,11 rather
than overall decision quality or (iii) did not weight
their components to produce an index measure
(i.e. were proﬁle instruments) or, if they did enable
weighting, did not elicit weights from the speciﬁc
patient on the speciﬁc decision occasion.
None of the instruments identiﬁed in the search constituted such a personalized preference-based measure
of decision quality. The only instruments uncovered
that used the label ‘decision quality’ per se were those
developed by Sepucha and colleagues.12 Their condition- and decision-speciﬁc decision quality instruments
(DQIs) include items that assess: (i) knowledge – the
extent to which the patient was ‘well informed’, (ii)
concordance – the level of agreement between the
patient’s goals and concerns and their treatment and
(iii) involvement – the extent to which the patient was
involved in decisions about their care. In addition to
the fact that they are not generic, these DQIs are not
preference-based. The scores that are produced relate to
particular segments of the DQI and are not aggregated,
by weighting, into a single overall index measure of
decision quality for the individual patient. Moreover,
the score for the concordance component is calculated
only for patient populations, not for any speciﬁc
patient.
We do not regard the Decisional Conﬂict Scale11 and
its 4-item form SURE13 as measures possessing construct validity in relation to decision quality because
they penalize decision processes and support systems
that leave the decision maker in a state of warranted
equipoise.
Decision satisfaction is not an appropriate measure
for assessing the quality of a decision aiding or making
process, and will often reward suppression of uncertainties rather than their expression.14 For example, item
two of the widely used Satisfaction with Decision
instrument (‘The decision I made was the best possible
choice for me’) makes it unsuitable in the evaluation of
decision quality because it denies the possibility that
there may be two or more best possible choices.10 We
regard patient empowerment as incompatible with the
notion that the role of the physician is to provide a
conﬁdent and single recommendation.

Defining decision quality
We take the view that both the deﬁnition and measurement of decision quality should be treated as preferencesensitive. Accordingly, in principle the measurement of
decision quality will require the decision owner to

112
choose which criteria to include in the instrument.
A DQI based on a set of consensus-led items and
weights (including the equal weights implied in most
checklists) seems incompatible with truly personalized
patient-centred care. While Edwards and Elwyn15 raise
a number of legitimate issues concerning the operationalization of decision quality, many of these stem from
their view that a ‘good decision’ exists, but is yet to be
deﬁned. In contrast, we take the view that decision quality – deﬁned tautologically as the goodness of a decision
– does not exist and should not be deﬁned in a positivistic way. ‘Decision quality’ is a multicriterial construct
and all we can do, given the necessity to assess it, is to
propose a set of items that appeal to our – and others’ –
value judgements as to what should be included. (In this
respect it parallels constructs like ‘health-related quality
of life’ that instruments such as EQ-5D simultaneously
deﬁne and measure.) Beyond this immediate challenge,
the next task that any one constructing a DQI faces is
operationalizing the measurement and synthesizing its
components. We interpret Edwards and Elwyn as agreeing with us that abdicating from this task because of the
substantial operational challenges it poses is not an
option, and we regard ‘subjective’ numerical
calculation as a vital complement to their ‘subjective’
verbal deliberation approach in responding to these
challenges.

Developing a personalized and generic
decision quality measure
MDQ is a web-based generic instrument for the individual-speciﬁc measurement of decision quality based on
Multi-Criteria Decision Analysis (MCDA).
Dolan recently explored the potential of MCDA as
the basis for decision support systems in health care,
including Shared Decision Making (SDM).16,17 He outlined the current portfolio of multicriteria methods and
commented on their respective merits and problems. His
assessment led him to favour the Analytic Hierarchy
Process (AHP) because it oﬀered greater ﬂexibility,
ease of use and strength of measurement compared
with the other methods. However, he acknowledged
that one of the main problems with using the AHP in
clinical decision support is that its pairwise comparison
elicitation processes, the main source of its strength in
measurement, is both time consuming and cognitively
demanding.
In conjunction with the online survey program called
Eliciaß in which it is embedded, Annalisaß forms an
interactive, online decision support template that was
explicitly designed to make MCDA-based decision support less temporally and cognitively demanding.18
It was not developed solely with applications in the
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health-care setting in mind, but it was designed to be
the basis for tools which were practical in both time and
resource-pressured situations – as well as relaxed ones.
Annalisa meets one of Bates et al.’s19 commandments
for the satisfactory delivery of a decision aid in stressing
visualization and presenting all aspects of the decision
(preferences, evidence and options) on a single screen.
Annalisa-based decision aids provide a structured analytical framework for decision deliberation and hence
for the balancing of the two main contributors to decision making – analytical modelling and intuitive judgement.20 Above all, Annalisa tools seek the requisite
balancing of normative rigour and operational practicality.21,22 A study involving an Annalisa tool for prostate cancer screening has conﬁrmed its ease of use.23
MDQ is a dually personalized DQI based on MCDA
and currently implemented in Annalisaß, though in
principle it could be implemented in any form of
online spreadsheet. (By saying MDQ is based on
MCDA we mean that there is always an implicit alternative decision process (option) with which the MDQ
result for the currently implemented option should be
compared.) The assessor (e.g. patient) is responsible not
only for (i) weighting the criteria of decision quality in
terms of their relative importance but also (ii) rating the
quality of a decision just made on the criteria. MDQ
is generic in the sense that the criteria are phrased without reference to any particular decision or context.
Information relating to the speciﬁc decision (such as
one in a particular health-care setting and population)
is to be provided outside the MDQ instrument, but in
the larger decision support system in which MDQ will
often be situated.18
As with all implementations of the simple ‘weightedsum’ version of MCDA, MDQ combines a set of
importance weights for multiple criteria with performance ratings for each option on these criteria and calculates the overall score as the expected value of these
components. The patient’s weightings for the eight criteria of decision quality are elicited as early as possible
in the decision-making process and their ratings on how
well the decision made performed on these criteria as
soon as possible after it was made. The MDQ Score,
unique to the patient and to the particular occasion, is
automatically calculated as the summed multiplication
of criterion weightings and ratings. A worked example
is provided in Figure 1.
Both MDQ and the decision aids developed in
Annalisa are accessible via the internet from any operating system, browser and on mobile tablets (iPad,
Android). The resulting summary picture of the decision quality assessment (showing Weightings, Ratings
and MDQ Score) can be printed and/or downloaded as
an image for later use, including sharing and formal
clinical documentation.
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Figure 1. Screen capture of Annalisa presentation of MDQ for patient PCS2880.

Figure 2. Screen capture of MyDecisionQuality weightings items (Ratings items are rephrased in past tense). Scale: 0 ¼ Not at all
important, 5 ¼ moderately important and 10 ¼ extremely important.

The desire to make MDQ practical in pressured situations such as a health-care clinic determined the
number of criteria included. The number that an individual could realistically be asked to weight and rate at
the time of decision making was initially set at 10. The
review of the most commonly used instruments in relation to patient involvement and participation in health
decision making helped us to generate a list of candidate criteria. This list was reduced to 10 on the basis of
either conceptual redundancy or inappropriateness for
inclusion in a universal (i.e. not speciﬁcally health) decision quality measure. These 10 included six items which
remained when it was later decided that eight was the
maximum practical number for a user to weight and
rate at the time of decision making and hence the maximum number of items to include in a decision quality
measure. This number is within Miller’s magical
number seven plus or minus two and is endorsed in
the Cochrane Handbook.24 The shorthand labels for
these six criteria are: ‘Options’, ‘Eﬀects’, ‘Importance’,
‘Trust’, ‘Control’ and ‘Commitment’. Of the remaining
four items in the original 10, an Uncertainty criterion
was subsumed in a ‘Chances’ criterion and an

Emotional Support item in a general ‘Support’
criterion.
Of the eight criteria in the current version of MDQ
(Figure 2), the ﬁrst four match the structural requirements for any MCDA implementation in any context
(Options, Criteria, Weightings and Ratings). These criteria also appear, in one form or another, in all checklists for developing decision aids for health decisions,
including IPDASi. The last four criteria relate to other
aspects of the decision process and are also explicitly or
implicitly included in most checklists for decision aids.
The ‘Commitment’ criterion creates for investigating
concordance at the point of decision and correspondence with future actions and outcomes.25
As with all the existing instruments referred to earlier there is no intention in MDQ to capture or assess
the subjective experience of the patient (fear, anxiety,
etc.). The patient expresses their views as to the support
they received in relation to their feelings and emotions –
and all other aspects of the decision experience – by
their weighting and rating on the Support criterion.
After discussions of the provisional eight items with
immediate colleagues, we uploaded an online survey
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Figure 3. Screen capture of Annalisa presentation of MDQ for patient PCS2880 showing MDQ Score breakdown and highlighting of
part-worth, weighting and rating for Options.

incorporating the initial MDQ on the Facebook page
of the SDM Group, and emailed an invitation to comment to those on the lists of the Society for
Medical Decision Making (SMDM) and Society of
Judgment and Decision Making in mid-December
2011. Allowing for crossover, we estimated that this
provided us with a few hundred potential respondents.
Twenty individuals completed the questionnaire (latest
in mid-January 2011) and nine also provided comments
on the MDQ screen. Their feedback was incorporated
in the re-development of the MDQ, when it was compatible with the underlying framework and construct.
Figure 1 shows the Weightings component of MDQ
as now adopted. The equivalent Ratings component of
MDQ is not presented here, but it is identical to the
Weightings except that the descriptions are phrased in
the past tense (e.g. ‘I was clear about the Options available to me and the processes they involve’).
While it is possible to have Users enter their weightings and ratings directly into Annalisa, early testing of
MDQ using a convenience sample of academics showed
that it was easier for their data to be elicited on a 0–10
scale in the survey program (Elicia) within which the
Annalisa for MDQ is embedded. The responses were
then mapped directly on to a 0–1 scale and ported into
Annalisa using the software bridge between the two
programs.
There are always tensions between what can be
expected from development of a practice-relevant tool
and one that is also used for research. Since the ﬁrst
(Weightings) part of MDQ is designed to be administered as early as possible in the decision-making process
it constitutes an intervention in itself, whether or not
any other intervention (e.g. decision aid) is involved
before the Rating part is administered. It is not at all
clear what should be the primary outcome, in terms of
decision quality, of a trial of MDQ-supplemented decision making and standard practice. The challenge of
validating a patient-speciﬁc, preference-based instrument such as MDQ does not appear to have been

addressed in the literature thus far and we continue
to seek assistance in this respect. Given the
personalized character of MDQ, we are particularly
interested in exploring the use of N-of-1 study
designs.26

Illustration of the application of MDQ
Figure 1 presents the MDQ screen of a patient from a
randomized controlled trial (RCT) using two Annalisabased decision aids for prostate cancer screening in
Australia.23 The Weightings shown are as they were
entered in Elicia in non-normalized format, that is,
they do not add to one. They are normalized in
Annalisa to add to one as the Score calculation is
always using normalized weights.
After seeing the MDQ Score, the patient has the
option of viewing its breakdown into the contributions
made by each criterion, that is, their ‘part-worths’, to
establish whether, and if so how, they might be able to
improve their MDQ Score in the future, provided the
opportunity exists. In Figure 3, the MDQ Score for
the patient is partitioned into eight segments. If a segment is relatively large then the criterion is making a
larger contribution to the individual’s MDQ Score.
On the other hand, if it is relatively small then it is
making a smaller contribution to their MDQ Score.
By placing the cursor over any segment of the MDQ
score bar, the relevant criterion label and the weightings and ratings for it are highlighted (column 1 in
Figure 3; video demonstration at http://bit.ly/
17yKWNm) If the patient has assigned the criterion
a small weighting but also a low rating there is no
need for concern. However, if they have assigned the
criterion a small rating but a moderate or large
weighting, they may want to think about how they
might change things for the better, for example, by
prioritizing the seeking of more information about
the eﬀects, more value clariﬁcation about criterion
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Figure 4. Incremental (Expected) Value of Perfect Ratings for each criterion for respondent PCS2880, shown as priority distribution.
The longest bar indicates biggest gain from perfect rating.

importance, moving towards their preferred level of
control or whatever the criterion relates to.
This feedback can be formalized in the form of the
Incremental (Expected) Value of Perfect Rating (IVPR)
(see Figure 4). The IVPR for a criterion indicates the
amount by which the overall MDQ Score could be
increased if, given the respondent’s weighting of a particular criterion, they achieved a (perfect) rating of one.
In the case of this patient, this would suggest priority
being given to improving the Rating for Options, followed by Eﬀects and Support.

Discussion
As we move towards patient-centred care it is important that we respond positively and wholly to patient
heterogeneity in the value aspects of decision
making.27 Developing a portfolio of instruments to
evaluate the overall quality of decisions in a transparent
and preference-sensitive manner is a growing area of
research. MDQ is oﬀered as one that may be able to
contribute to this process.
Given its preference-sensitive nature how might
MDQ be used to advance patient-centred research?
Patients are heterogeneous in both their biophysical proﬁle and their preferences. Because of the preference-sensitive nature of the instrument, the usefulness of average
results (Weightings, Ratings and MDQ Scores) from
MDQ depends on the purpose of using it in the ﬁrst
place. If a patient uses MDQ to assess the quality of a

decision made after using an online decision aid and
prints out the MDQ screen, this may be used during a
clinical consultation follow-up to form the basis of a
tailored conversation about particular aspects of the
decision. In this case, it is only the individual patient’s
Weightings, Ratings and Score that matter. On the other
hand, for an RCT involving simple and complex versions of a decision aid, average MDQ scores may be
used to compare decision quality across the two arms
of the trial. However, these results still need to be carefully interpreted in light of the personalized criterion
weightings they embody. In principle, the average results
matter most where health-care resources are being consumed or a relevant group- or population-level policy
decision is to be taken.22 In this respect, cluster and
latent class analysis28 may be used to establish meaningful patterns of preferences in the community,29 leading
to an ‘epidemiology of preferences’.
In relation to the Annalisa-based decision aids we
are developing, we envisage an alternative route
where the individual selects the criteria most important
to them from a longer list rather than having a set of
criteria provided by researchers. We refer to this as a
‘Pick Your Own’ version of a decision aid. This version
formed one of the arms of the clinical trial involving
two decision aids for prostate cancer screening.30
A ‘Pick Your Own’ version of (MDQ) captures the
essence of person-centred care but it is essential
that any such alternative patient-reported MDQ measure retains its theoretical and prescriptive basis
in MCDA.
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